NCT06556290 Effect of a Casein and Gluten Free Diet in Mexican Children With Autism Spectrum Disorder
| NCT ID | NCT06556290 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Guadalajara |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-02-12 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-02-12 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assess the effect of a casein-free and gluten-free diet on gastrointestinal symptoms, clinical variables, and the composition of the intestinal microbiota in Mexican children with autism spectrum disorder.
Eligibility Criteria
Inclusion Criteria: Children between 4-10 years old diagnosed with autism spectrum disorder using the criteria established in the ADOS scale and the CARS. Exclusion Criteria: Children who have received: * Antibiotics * Antimycotics * Probiotic supplements * Prebiotic supplements * Any medication that may alter the microbial composition of the patient, minimum one month prior to sampling. * Children on a strict dietary regimen other than a casein-free and gluten-free diet. * Children with celiac disease or who present any gluten-related disorder. * Children with allergy to dairy products.
Contact & Investigator
Nora M. Torres Carrillo, Ph.D.
PRINCIPAL INVESTIGATOR
University of Guadalajara
Frequently Asked Questions
Who can join the NCT06556290 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 10 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06556290 currently recruiting?
Yes, NCT06556290 is actively recruiting participants. Contact the research team at nora.torres@academicos.udg.mx for enrollment information.
Where is the NCT06556290 trial being conducted?
This trial is being conducted at Guadalajara, Mexico.
Who is sponsoring the NCT06556290 clinical trial?
NCT06556290 is sponsored by University of Guadalajara. The principal investigator is Nora M. Torres Carrillo, Ph.D. at University of Guadalajara. The trial plans to enroll 20 participants.